Hot Topics

Blog

Update on Antibody Testing for SARS-CoV-2/ COVID-19

February 2021: Penn Medicine has different serologic tests for SARS-CoV-2 virus that are orderable in Penn Chart. The newest addition to the antibody testing category is a test to measure receptor binding domain (RBD) IgG and RBD IgA antibodies. This post outlines the types of SARS-CoV-2 antibody testing available, when it may be appropriate to order such testing, and how to interpret the results.

read more
Info

Pathology & Laboratory Medicine Update on COVID-19 Testing

Below is the most recent announcement regarding COVID-19 from the Department of Pathology & Laboratory Medicine.

Read more
Blog

Contributions from our Research Community and from the Department's IDEA Committee

Every single one of us has a crucial role to play, both in fighting the pandemic and for incorporating equity into our teaching, research, and laboratory practice.

read more
publication

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2

Mark Dittmar, Jae Seung Lee, Kanupriya Whig, Elisha Segrist, Minghua Li, Brinda Kamalia, Lauren Castellana, Kasirajan Ayyanathan, Fabian L Cardenas-Diaz, Edward E Morrisey, Rachel Truitt, Wenli Yan

Read more
News

Penn Medicine Team Uncovers Several Drugs That Could Treat COVID-19

Cell Reports study by Cherry Lab includes promising candidates already approved by FDA such as widely used transplant-rejection drug cyclosporine.

Read more